Related Experiment Video
Updated: May 13, 2026
08:58
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
Published on: October 17, 2025
Adaptive enrichment designs for clinical trials
1Department of Statistics, Stanford University, Stanford, CA 94305, USA.
Biostatistics (Oxford, England)
|March 26, 2013
Summary
Adaptive enrichment designs improve clinical trials by updating patient eligibility criteria during the study. This targets treatments to patients most likely to benefit, enhancing trial efficiency and safety.
Area of Science:
- Clinical trial methodology
- Biostatistics
- Precision medicine
Background:
- Modern medicine increasingly uses targeted therapeutics for disease heterogeneity.
- Current clinical trials often enroll broad patient populations, necessitating post hoc analyses to identify responders.
- This approach can expose non-benefiting patients to adverse effects and reduce trial efficiency.
Purpose of the Study:
- To propose adaptive enrichment designs for clinical trials.
- To allow dynamic modification of eligibility criteria during a trial.
- To restrict trial enrollment to patients predicted to benefit from novel treatments.
Main Methods:
- Development of a class of adaptive enrichment designs.
- Simulation studies to evaluate design performance.
- Analysis of type 1 error preservation and power.
Main Results:
- Proposed designs maintain statistical type 1 error.
- Adaptive enrichment designs demonstrate substantial power increases in various scenarios.
- Improved identification of patient subsets who benefit from targeted therapies.
Conclusions:
- Adaptive enrichment designs offer a more efficient and ethical approach to clinical trials for targeted therapies.
- These designs enhance the precision of identifying patient subgroups likely to respond to novel treatments.
- Implementation can optimize resource allocation and patient safety in drug development.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:20Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...